As one of the three key components of photodynamic therapy(PDT),photosensitizers(PSs)greatly influence the photodynamic efficiency in the treatment of tumors.Photosensitizers with tetrapyrrole structure,such as porphy...As one of the three key components of photodynamic therapy(PDT),photosensitizers(PSs)greatly influence the photodynamic efficiency in the treatment of tumors.Photosensitizers with tetrapyrrole structure,such as porphyrins,chlorins and phthalocyanines,have been extensively investigated for PDT and some of them have already received clinical approval.However,only a few of porphyrin-based photosensitizers are available for clinical applications,and PDT has not received wide recognition in clinical practice.In this regard,PSs remain a limiting factor.Our research focuses on the rational design of new PSs.Photocyanine,a Zinc(Ⅱ)phthalo-cyanine(ZnPc)type photosensitizer with low dark toxicity and high single oxygen quantum yield,is one of the promising PSs candidates and currently being tested in clinical trials.Here,we present an overview on the development of Photocyanine,including its design,synthesis,purification,characterization and preclinical studies,wishing to contribute to the research of more promising PSs.展开更多
Escherichia coli(E. coli) DH5α has been recognized as a non-pathogenic bacterial strain with tumor colonization ability. However, whether such a bacteria-driven drug-delivery system can improve the targeting of tumor...Escherichia coli(E. coli) DH5α has been recognized as a non-pathogenic bacterial strain with tumor colonization ability. However, whether such a bacteria-driven drug-delivery system can improve the targeting of tumor therapy or not remains essentially untouched. Herein, a series of zinc phthalocyanine(ZnPc) photosensitizers with different numbers of charges were prepared and their electrostatic adhesion properties on E. coli were investigated via measuring their fluorescence intensities by flow cytometer. Among these ZnPc photosensitizers investigated, the ZnPc conjugate with four positive charges(named ZnPc-IR710) exhibited the highest loading capacity and the best fluorescence imaging performance of E. coli. With the help of E. coli, E. coli@ZnPcIR710 presented a significantly enhanced cytotoxicity on human breast cancer MCF-7 cells compared with ZnPc-IR710(survival rate of tumor cells was 39% vs. 57% at a concentration of 50 nmol L-1). Moreover, in vivo study showed that E. coli@ZnPc-IR710 remarkably inhibited the tumor growth and resulted in a complete tumor growth suppress in subcutaneous mouse 4T1 breast tumor model. These results demonstrated the great promise of bacterial-guided photodynamic therapy(PDT) in the treatment of solid tumors, and provide a unique strategy to enhance the antitumor efficacy of PDT by utilizing bacterial vectors in tumors.展开更多
基金financially supported by grants from National Key R&D Program of China(2017YFE0103200)National Science and Tech-nology Major Projects for"Major New Drugs In-novation and Development"(Grant number 2011ZX09101-001-04)Natural Science Foundation of China(31370737,31670739)
文摘As one of the three key components of photodynamic therapy(PDT),photosensitizers(PSs)greatly influence the photodynamic efficiency in the treatment of tumors.Photosensitizers with tetrapyrrole structure,such as porphyrins,chlorins and phthalocyanines,have been extensively investigated for PDT and some of them have already received clinical approval.However,only a few of porphyrin-based photosensitizers are available for clinical applications,and PDT has not received wide recognition in clinical practice.In this regard,PSs remain a limiting factor.Our research focuses on the rational design of new PSs.Photocyanine,a Zinc(Ⅱ)phthalo-cyanine(ZnPc)type photosensitizer with low dark toxicity and high single oxygen quantum yield,is one of the promising PSs candidates and currently being tested in clinical trials.Here,we present an overview on the development of Photocyanine,including its design,synthesis,purification,characterization and preclinical studies,wishing to contribute to the research of more promising PSs.
文摘形成血管和淋巴管内层的内皮细胞是脉管系统的重要组成部分,并参与血管和淋巴系统疾病的发病机制。内皮细胞上的血管生成素(Angiopoietin,Ang)-具有免疫球蛋白和表皮生长因子同源性结构域的酪氨酸蛋白激酶(Tyrosine kinase receptors with immunoglobulin and EGF homology domains,Tie)轴是除了血管内皮生长因子受体途径外胚胎心血管和淋巴发育所必需的第二种内皮细胞特异性配体-受体信号传导系统。Ang-Tie轴参与调节产后血管生成与重塑、血管通透性和炎症,以维持血管平衡,因此,该系统在许多血管和淋巴系统疾病中发挥重要的作用。针对近年来Ang-Tie轴在血管和淋巴系统相关疾病中作用的研究进展,文中系统论述了Ang-Tie轴在炎症诱导的血管通透性、血管重塑、眼部新生脉管、剪切应力反应、动脉粥样硬化和肿瘤血管生成和转移中的作用,并总结了涉及Ang-Tie轴的相关治疗性抗体、重组蛋白和小分子药物。
基金supported by the National Natural Science Foundation of China (81572944, 21471033, 21877113 and 81971983)the CAS/SAFEA International Partnership Program for Creative Research Teams, the High-Level Entrepreneurship and Innovation Talents Projects in Fujian Province (2018-8-1)the FJIRSM&IUE Joint Research Fund (RHZX-2018-004)。
文摘Escherichia coli(E. coli) DH5α has been recognized as a non-pathogenic bacterial strain with tumor colonization ability. However, whether such a bacteria-driven drug-delivery system can improve the targeting of tumor therapy or not remains essentially untouched. Herein, a series of zinc phthalocyanine(ZnPc) photosensitizers with different numbers of charges were prepared and their electrostatic adhesion properties on E. coli were investigated via measuring their fluorescence intensities by flow cytometer. Among these ZnPc photosensitizers investigated, the ZnPc conjugate with four positive charges(named ZnPc-IR710) exhibited the highest loading capacity and the best fluorescence imaging performance of E. coli. With the help of E. coli, E. coli@ZnPcIR710 presented a significantly enhanced cytotoxicity on human breast cancer MCF-7 cells compared with ZnPc-IR710(survival rate of tumor cells was 39% vs. 57% at a concentration of 50 nmol L-1). Moreover, in vivo study showed that E. coli@ZnPc-IR710 remarkably inhibited the tumor growth and resulted in a complete tumor growth suppress in subcutaneous mouse 4T1 breast tumor model. These results demonstrated the great promise of bacterial-guided photodynamic therapy(PDT) in the treatment of solid tumors, and provide a unique strategy to enhance the antitumor efficacy of PDT by utilizing bacterial vectors in tumors.